Q1. Identify the main environment forces currently affecting the pharmaceutical industry. PESTLE analysis is used to help the organization to understand what is the current status of the organization and the external factors that are affecting it, whereas this also helps the management of the organizations to overcome the weak areas organizations by implementing the strategy for the future. Political The policies of the government had a great effect on the regulations and legal issues that
Words: 1567 - Pages: 7
a strategy for delaying the entry of generics into the marketplace. It must be understood that once the patent’s exclusivity period of the existing medicine is over, any company may produce that particular chemical entity as long as regulatory requirements are met2. Generic drug companies in India have argued that evergreening has directly threatened their ability to produce drugs at a cost that is accessible to poor people. However, as we now know, the generic drug company can produce the original
Words: 884 - Pages: 4
| Pharmaceutical companies | Research Paper | | Daren Smith | 5/21/2012 | | Abstract There is a lot of discussion about pharmaceutical companies, intellectual property, and the global AIDS epidemic. Do pharmaceutical companies have a responsibility to distribute drugs for free or low cost in developing countries? Why is intellectual property such a big deal? What impact would South Africa’s decision to levy duties on drugs in the country have on the international distribution
Words: 2390 - Pages: 10
A Rose by Any Other Name Case Study Case One The Dilemma: Rose Partyware has been working towards creating its own brand of party ware supplies to give it a competitive edge in an industry of generic party supply manufacturers. Recently, Rose Partyware was presented with the opportunity to produce a private-label brand of party goods. This alternative would provide Rose with a stable revenue source as well as opportunities to create private-labels for other retailers. However, pursuing this
Words: 317 - Pages: 2
The Upjohn Corporation began in 1885 when its founder, W.E. Upjohn, obtained a patent for a new type of pill. In it early stages Upjohn experienced rapid growth helping it become a low cost leader and possess a differentiation advantage over its competitors. Decisions concerning profit margin led the then directors of Upjohn to focus on research and development in order to take advantage of the perceived luxury market and its higher profit margins. This has led to a large portion of the budget being
Words: 1022 - Pages: 5
PA C T CHAIRMAN’S LETTER 2009-10 has been a satisfactory year for your Company. Let me start with the financial results. Consolidated revenues for 2009-10 was Rs. 70,277 million. Excluding revenues from sumatriptan — your Company’s Authorized Generic version of Imitrex® which was launched in 2008-09 — revenue grew by 9%. In US dollar terms, 2009-10 revenue was US$ 1.56 billion. I am happy to inform you that the Company’s revenue has been rising at a CAGR of 23% over the last decade. That is a
Words: 111729 - Pages: 447
of general environment. In pharmaceutical industry we have two kind of medications which are generic or innovative. Innovative pharmaceutical industry success depends on the patent protection in the industry. For example, in United States innovative industry can have 10 to 12 years of patent protection life from the time that product is for sale in the market. Success of the generic pharmaceuticals which are bioequivalent to innovative pharmaceutical is also related to the
Words: 298 - Pages: 2
Executive Summary The following analysis of Merck and Company was to thoroughly examine a drug licensing opportunity with LAB Pharmaceuticals, a small pharmaceutical firm. This firm has offered to allow Merck and Company rights to further development of the drug called Davanrik. The analysis includes calculations of probability and decision trees using the Microsoft program Excel. It is assumed that given probabilities are correct, however sensitivity analyses were conducted to show the overall effect
Words: 1914 - Pages: 8
drug. o • Independent firm exploited parallel trade by using the differentials in price across various countries. • Generic Drugs: unbranded drugs of comparable efficacy available at fractional cost of branded product. o o o Posed as major challenge for pricing power of large pharma companies. No additional expense for drug R&D of new compounds. Generic companies made money by copying the products discovered & developed by other major pharmaceuticals
Words: 2071 - Pages: 9
TOPIC : RANBAXY LABORATORIES Submitted to: Prof. Deepak Shyam MBA Dept Submitted by: Nithin Unnikrishnan Nair 1PT12MBA36 CONTENT * INTRODUCTION * VISION AND MISSION * INDUSTRY ANALYSIS(PORTER’s FIVE MODEL) * SWOT ANALYSIS * COMPETITIVE STRATEGY OF RANBAXY * BCG MATRIX * GLOBAL STRATEGY FOR GROWTH * RANBAXY LABORATORIES INTRODUCTION Ranbaxy Laboratories
Words: 813 - Pages: 4
